Hemlibra found to ease pain, improve life quality in hemophilia A
Hemlibra (emicizumab), a preventive treatment for hemophilia A, reduced pain and improved quality of life for adults and…
Articles by Esteban Dominguez Cerezo, MS
Immunotherapy helps suppress inhibitors in acquired hemophilia A
Immunotherapy is an effective treatment strategy to suppress the production of autoantibodies and induce remission in people with acquired…
Obizur effective as acquired hemophilia A treatment: Study
Obizur (susoctocog alfa) is an effective and safe therapeutic option for the treatment of severe bleeding episodes in people…
Over 10% of men with hemophilia report restricted sexual functioning
More than 1 in 10 men with hemophilia reported being restricted in their sexual…
Hemophilia prophylaxis tied to less disability-related unemployment
Prophylactic treatment for hemophilia can help people with the disease avoid unemployment due to disability, a study reports. Hemophilia…
Gene therapy Durveqtix OK’d for use in Europe for hemophilia B
Durveqtix (fidanacogene elaparvovec), a gene therapy for adults with severe and moderately severe hemophilia B, has been…
CADTH recommends hemophilia B gene therapy reimbursement
The Canadian Agency for Drugs and Technologies in Health’s (CADTH) Canadian Drug Expert Committee (CDEC) recommended reimbursement for hemophilia…